Crossmark

In vitro evaluation of anticoagulant therapy management when urgent percutaneous coronary intervention is required in rivaroxaban-treated patients

Published Online: 2023-05-20

Published Print: 2023-11

Authors

Melek, Mehmet

Ari, Hasan

Ari, Selma

Cilgin, Mehmet Can

Yarar, Mücahit

Huysal, Kagan

Ağca, Fahriye Vatansever

Bozat, Tahsin
License Information

Text and Data Mining valid from 2023-05-20

Version of Record valid from 2023-05-20
More Information

Article History

Received: 28 November 2022

Accepted: 15 May 2023

First Online: 20 May 2023

Declarations

:

: This trial was approved by the Bursa Yuksek Ihtisas Training and Research Hospital, Clinical Research Ethics Committee; 2011-KAEK-25 2021/03-22.

: The authors declare no competing interests.

Document is current